Eko Low Ejection Fraction Tool (ELEFT) vs Us2.v2
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 68/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
ELEFT is designed for early screening of low ejection fraction during routine physical exams using digital stethoscopes. In contrast, Us2.v2 automates the comprehensive interpretation and reporting of full echocardiograms, detecting a wider range of cardiac conditions. While both leverage AI in cardiology, ELEFT serves as a front-line screening tool, whereas Us2.v2 provides detailed diagnostic analysis post-echocardiogram.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Eko Low Ejection Fraction Tool (ELEFT) is designed for early detection of low ejection fraction during routine physical exams using an Eko digital stethoscope, providing rapid screening results in approximately 15 seconds. Us2.v2 automates the interpretation of existing echocardiograms, delivering comprehensive structured reports with measurements and disease detection, primarily for post-acquisition analysis to reduce reporting time and increase throughput.
Us2.v2 offers seamless integration with existing PACS, CVIS, or EMR systems, supporting HL7 and DICOM SR for automated report delivery. ELEFT integrates with Eko digital stethoscopes and is part of the cloud-based SENSORAu2122 platform, with less explicit detail on direct EHR/PACS integration beyond cloud-based data processing and storage.
ELEFT focuses specifically on aiding in the early detection of low ejection fraction (LVEF u2264 40%), making it suitable for Cardiology, Family Medicine, and Internal Medicine for screening. Us2.v2 provides automated detection for a broader range of conditions including cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease, primarily targeting Cardiology.
Us2.v2 features guideline-adherent and explainable AI with transparent visual overlays and editable outputs, ensuring every result is traceable and fully editable by the clinician. ELEFT aids clinicians in detection, providing results quickly, but specific features for auditability or explainable AI beyond clinician over-read are not detailed.
ELEFT has a potentially low learning curve as it integrates into routine physical exams with a digital stethoscope, offering rapid results in about 15 seconds and immediate screening value. Us2.v2 automates complex echo interpretation, which can significantly reduce reporting time by up to 70% and increase daily scan throughput, providing value through efficiency gains.
ELEFT is part of Eko's SENSORAu2122 platform, an enterprise solution, suggesting it's designed for broader deployment across an organization. Us2.v2 offers both cloud and on-premise deployment options and integrates with existing PACS, CVIS, or EMR systems via standard DICOM routing, providing flexibility for multi-site rollouts.
More Comparisons
Backers
Who funded each tool's parent company.